Naz Chaudary

Ontario Cancer Institute, University Health Network

Affiliated withUniversity Health Network University Health Network

Research Area

Biography

Naz Chaudary has not added Biography.
If you are Naz Chaudary and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 17	2015

Other Publications

Article	Year
Transport characteristics of HL-1 cells: a new model for the study of adenosine physiology in cardiomyocytes. Biochemistry and cell biology = Biochimie et biologie cellulaire\| PubMed ID: 12440705	2002
Hypoxia regulates the adenosine transporter, mENT1, in the murine cardiomyocyte cell line, HL-1. Cardiovascular research\| PubMed ID: 14985075	2004
The adenosine transporter, mENT1, is a target for adenosine receptor signaling and protein kinase Cepsilon in hypoxic and pharmacological preconditioning in the mouse cardiomyocyte cell line... The Journal of pharmacology and experimental therapeutics\| PubMed ID: 15131243	2004
Hypoxia and metastasis. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 17404073	2007
Hypoxia and metastasis in breast cancer. Breast disease\| PubMed ID: 17473365	2006-2007
The tumor microenvironment and metastatic disease. Clinical & experimental metastasis\| PubMed ID: 18543068	2009
Increased expression of metastasis-related genes in hypoxic cells sorted from cervical and lymph nodal xenograft tumors. Laboratory investigation; a journal of technical methods and pathology\| PubMed ID: 19308047	2009
Characterization of mammalian equilibrative nucleoside transporters (ENTs) by mass spectrometry. Protein expression and purification\| PubMed ID: 20399865	2010
Suppression of vascular endothelial growth factor receptor 3 (VEGFR3) and vascular endothelial growth factor C (VEGFC) inhibits hypoxia-induced lymph node metastases in cervix cancer. Gynecologic oncology\| PubMed ID: 21839498	2011
Orthotopic xenograft model of cervical cancer for studying microenvironmental effects on metastasis formation and response to drug treatment. Current protocols in pharmacology / editorial board, S.J. Enna (editor-in-chief) ... [et al.]\| PubMed ID: 21935900	2011
Hedgehog pathway signaling in cervical carcinoma and outcome after chemoradiation. Cancer\| PubMed ID: 22028038	2012
Tumor-stroma interaction in orthotopic primary pancreatic cancer xenografts during hedgehog pathway inhibition. International journal of cancer. Journal international du cancer\| PubMed ID: 23280784	2013
Hypoxia and metastasis in an orthotopic cervix cancer xenograft model. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 23856487	2013
Hypoxic activation of the PERK/eIF2α arm of the unfolded protein response promotes metastasis through induction of LAMP3. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 24045183	2013
Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx). Cancers\| PubMed ID: 24213469	2012
Heat-activated thermosensitive liposomal cisplatin (HTLC) results in effective growth delay of cervical carcinoma in mice. Journal of controlled release : official journal of the Controlled Release Society\| PubMed ID: 24440663	2014
Single-cell measurement of the uptake, intratumoral distribution and cell cycle effects of cisplatin using mass cytometry. International journal of cancer. Journal international du cancer\| PubMed ID: 25042623	2015
Establishment of orthotopic primary cervix cancer xenografts. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 25348321	2015
The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer. Oncotarget\| PubMed ID: 25473903	2015
Cyclic hypoxia does not alter RAD51 expression or PARP inhibitor cell kill in tumor cells. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 25842967	2015
Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study. International journal of radiation oncology, biology, physics\| PubMed ID: 26547383	2015